Posts
Eli Lilly's obesity pill remains a viable rival to Novo's...
Eli Lilly's orforglipron could have a few advantages over a pill from Novo Nordisk,...
A world on weight loss drugs: How GLP-1s are reshaping...
As GLP-1 adoption grows and new applications for the drugs come to light, experts...
Eli Lilly’s weight loss pill orforglipron clears its latest...
Eli Lilly now has the clinical trial data required to start filing for approvals...
Healthy Returns: Eli Lilly’s chief scientific officer breaks...
Eli Lilly's Daniel Skovronsky talks the latest orforglipron trial, while UnitedHealth...
SpaceX makes comeback with Starship test launch after fiery...
SpaceX has pulled off a successful launch after a string of explosive setbacks earlier...
SpaceX makes comeback with Starship test launch after fiery...
SpaceX has pulled off a successful launch after a string of explosive setbacks earlier...
European stocks rebound as traders eye Nvidia earnings
European markets opened higher Wednesday as global traders gear up for results from...
European stocks rebound as traders eye Nvidia earnings
European markets opened higher Wednesday as global traders gear up for results from...
Asia-Pacific markets trade mixed as investors assess China...
Asia-Pacific markets mostly fell on Wednesday with U.S. tariffs on India set to...
Hong Kong markets lead losses in Asia-Pacific as investors...
Trump reportedly warned of "200% tariffs or something" on China if it does not export...
.jpg&h=630&w=1200&q=100&v=1be2781027&c=1)
.jpg&h=630&w=1200&q=100&v=1be2781027&c=1)
